Loading...

GUTS FRACTYL HEALTH INC US FDA Inspections 8-K Filing

FRCT

GTS

FRACTYL HEALTH INC

(GUTS)

2025 8-K

Summary

Summary

Stockholder Meeting

Stock Offering Announcement

Interim Study Results

Equity Offerings

Product Expansion

Post-Market Surveillance

Clinical Trials

Product Expansion

Financial Statements

Positive Study Data

Annual Meeting Notice

Financial Results

Clinical Study Update

New Therapy Candidate

External Links:

On June 18, 2025, Fractyl Health, Inc. announced the issuance of two new patents related to duodenal resurfacing technologies, further enhancing its intellectual property portfolio, with U.S. Patent No. 12,329,439 issued on June 17, 2025, and U.S. Patent No. 12,303,185 issued on May 20, 2025.

AI Assistant

FRACTYL HEALTH INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.